EUVIMEDOpdag EUVIMED
Open access

The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes

Nicola Marrano iD, Anna Borrelli, Giuseppina Biondi iD, Martina Rella iD, Rossella D'Oria iD, Valentina Annamaria Genchi iD, Cristina Caccioppoli, Valerio Galasso iD, Giovanni Galluzzi iD, Luca Roberto, Anna Signorile, Leonardo Vincenti iD and 12 more

Science Advances · 2026-06-05 · 12 (23)

DOI: 10.1126/sciadv.aee4804 ↗

At a glance

Journal article in Science Advances, published on 2026-06-05. Written by Nicola Marrano and 23 co-authors. Institution: Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Uni…. Major MEDLINE topics: Diabetes Mellitus, Type 2, Fibronectins, Insulin-Secreting Cells, Diabetes Mellitus, Experimental. Cited 2 times so far (Crossref); 84 references. The full text is freely available in PubMed Central. Funded by: European Social Fund, Ministero dello Sviluppo Economico, Regione Puglia.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Irisin is a myokine that enhances insulin secretion and β cell viability in both rodent and human β cells. Here, we investigated whether irisin preserves β cell functional mass in vivo in diabetic mice and ex vivo in human pancreatic islets from subjects with type 2 diabetes (T2D). In mice made diabetic by a high-fat diet and streptozotocin, irisin administration improved glycemic homeostasis by increasing islet insulin content and glucose-stimulated insulin secretion while also markedly stimulating β cell proliferation. In islets from T2D subjects, which typically display substantial structural and functional impairments, irisin restored insulin content and glucose-stimulated insulin secretion. Mechanistic studies in INS-1E cells showed that chronic exposure to high glucose blunted glucose-triggered cytoplasmic calcium increases, essential for insulin secretion. Under these glucotoxic conditions, while irisin was unable to activate CREB and AKT, it induced AMPK-mTORC1-S6K–dependent mobilization of endoplasmic reticulum calcium stores, resulting in enhancement of insulin secretion. Overall, these findings highlight irisin’s multifaceted ability to counteract β cell failure in experimental and human T2D.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2FibronectinsInsulin-Secreting CellsDiabetes Mellitus, ExperimentalHumansAnimalsMyokinesMiceInsulinInsulin SecretionGlucoseCalciumMaleCell Proliferation

Substances

FibronectinsMyokinesInsulinFNDC5 protein, humanGlucoseCalciumFNDC5 protein, mouse

Authors and institutions

  • Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
  • Transgenic Mice Facility, Biogem S.c.ar.l., Ariano Irpino, Avellino, Italy.
  • Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy.
  • General Surgery Unit, National Institute of Gastroenterology "Saverio de Bellis," Research Hospital, Castellana Grotte, Bari, Italy.
  • Diabetes Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.
  • Institute of Sciences of Food Production, National Research Council of Italy, (CNR-ISPA), Bari, Italy.

ORCID profiles: Nicola Marrano, Giuseppina Biondi, Martina Rella, Rossella D'Oria, Valentina Annamaria Genchi, Valerio Galasso, Giovanni Galluzzi, Leonardo Vincenti, Fabrizio Aquilino, Piero Marchetti, Lorenzo Piemonti, Angelo Cignarelli, Sebastio Perrini, Francesco Giorgino, Annalisa Natalicchio

Funding

  • European Social Fund
  • Ministero dello Sviluppo Economico
  • Regione Puglia
  • European Union
  • Fondazione per la Ricerca Biomedica Saverio e Isabella Cianciola

Cite

APA

Marrano, N., Borrelli, A., Biondi, G., Rella, M., D'Oria, R., Genchi, V. A., Caccioppoli, C., Galasso, V., Galluzzi, G., Roberto, L., Signorile, A., Vincenti, L., Aquilino, F., Nano, R., Baruzzi, F., Moretti, A., Lupo, L. G., Marchetti, P., Piemonti, L., …, & Natalicchio, A. (2026). The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes. Science Advances, 12(23). https://doi.org/10.1126/sciadv.aee4804

Vancouver

Marrano N, Borrelli A, Biondi G, Rella M, D'Oria R, Genchi VA, et al. The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes. Science Advances. 2026;12(23). doi:10.1126/sciadv.aee4804

BibTeX
@article{Marrano2026,
  author = {Marrano, Nicola and Borrelli, Anna and Biondi, Giuseppina and Rella, Martina and D'Oria, Rossella and Genchi, Valentina Annamaria and Caccioppoli, Cristina and Galasso, Valerio and Galluzzi, Giovanni and Roberto, Luca and Signorile, Anna and Vincenti, Leonardo and Aquilino, Fabrizio and Nano, Rita and Baruzzi, Federico and Moretti, Antonio and Lupo, Luigi Giovanni and Marchetti, Piero and Piemonti, Lorenzo and Cignarelli, Angelo and Perrini, Sebastio and Laviola, Luigi and Giorgino, Francesco and Natalicchio, Annalisa},
  title = {The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {23},
  doi = {10.1126/sciadv.aee4804}
}
Start for free →